Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Differential effects of TSPO ligands on functional connectivity and metabolism during fear and anxiety
DRKS00020267Phase 3Completed
- Sponsor
- medbo
- Start
- Oct 2020
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in specific phobia comparing Etifoxine (Stresam), Alprazolam and Placebo (3 arms). Started Oct 2020; status: completed.
02
Drugs
etifoxinealprazolam
03
Conditions
specific phobia
Beyond the preview
Go deeper on DRKS00020267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020267.